<DOC>
	<DOCNO>NCT02444494</DOCNO>
	<brief_summary>The objective non-interventional study evaluate clinical effectiveness cost effectiveness Dysport within reimbursement scheme call `` drug programme '' fund Polish National Health Fund ( NHF ) patient post stroke ULS . The study design collect data patient schedule receive Dysport treatment drug programme , base routine treatment subject ULS .</brief_summary>
	<brief_title>Study Document Effectiveness Dysport Patients Suffering From Upper Limb Spasticity ( ULS ) After Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<criteria>≥ 18 year age . A history ischemic haemorrhagic stroke minimum 3 month prior inclusion drug programme , document discharge hospital . Poststroke spasticity confirm upper extremity moderate high ( result modify Ashworth scale MAS ≥ 2 ) least one muscle group . Classification patient programme occur patient designated date commencement medical rehabilitation confirm provide rehabilitation service . Drug administration need take place earlier three week start medical rehabilitation . Written informed consent give patient occurrence study related procedure . Patient already include NHF Dysport programme . Severe dysphagia respiratory disorder . Pregnancy Myasthenia gravis myasthenic syndrome base neurological examination ( additional test justify case ) . Generalized symptoms infection The presence inflammation within plan site administration . Fixed contractures soft tissue joint . Dementia medium deep cycle ( score mini mental state examination ( MMSE ) equal less 18 point ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>